Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 48 | 1 | 5 | 1 | €222.50 | €270.99 | 21.793% |
| Alkermes plc | 17 | 2 | 0 | 0 | €24.00 | €35.01 | 45.888% |
| Medpace Holdings Inc | 16 | 0 | 0 | 0 | €303.10 | €416.61 | 37.449% |
| Novocure Ltd | 1 | 0 | 0 | 0 | €15.08 | - | - |
| Iovance Biotherapeutics Inc. | 20 | 1 | 1 | 0 | €9.02 | €25.72 | 185.011% |
| United Therapeutics | 27 | 1 | 3 | 0 | €311.80 | €315.21 | 1.093% |
| Taro Pharmaceutical Industries Ltd | 9 | 0 | 0 | 0 | €40.00 | - | - |
| Icon plc | 24 | 0 | 0 | 0 | €282.90 | €324.79 | 14.807% |
| QIAGEN NV | 12 | 0 | 0 | 0 | €40.47 | €47.52 | 17.415% |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 0 | 0 | €43.01 | €56.72 | 31.880% |
| Evotec SE | 10 | 1 | 8 | 0 | €5.98 | €7.00 | 17.057% |
| Charles River Labs Intl | 13 | 0 | 2 | 0 | €172.10 | €247.61 | 43.874% |
| Exelixis Inc. | 21 | 0 | 2 | 0 | €23.05 | €26.01 | 12.826% |
| Neurocrine Bioscience | 44 | 0 | 4 | 0 | €108.35 | €149.47 | 37.953% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €54.14 | €55.00 | 1.588% |
| Hutchison China MediTech Ltd ADR | 3 | 0 | 0 | 0 | €15.70 | €20.23 | 28.855% |
| Acadia Pharmaceuticals | 35 | 1 | 6 | 0 | €14.62 | €29.92 | 104.620% |
| Repligen Corp. | 15 | 0 | 0 | 0 | €132.70 | €178.01 | 34.146% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| Dr. Reddy's Laboratories Ltd. ADR | 7 | 1 | 0 | 0 | €71.00 | €75.37 | 6.156% |
| Emergent Biosolutions Inc. | 9 | 2 | 5 | 0 | €6.79 | €7.44 | 9.664% |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | €1.02 | €2.40 | 136.453% |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | €25.38 | €35.01 | 37.925% |
| Bausch Health Companies Inc. | 6 | 0 | 1 | 0 | €5.58 | €12.95 | 132.054% |
| Halozyme Therapeutics Inc. | 22 | 0 | 4 | 0 | €53.36 | €56.47 | 5.826% |